Hutz MH - Search Results

1

Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity.

Szobot CM, Roman T, Hutz MH, Genro JP, Shih MC, Hoexter MQ, Júnior N, Pechansky F, Bressan RA, Rohde LA. Szobot CM, et al. Among authors: hutz mh. Synapse. 2011 Feb;65(2):154-9. doi: 10.1002/syn.20829. Synapse. 2011. PMID: 20593420 Clinical Trial.

2

Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.

Roman T, Rohde LA, Hutz MH. Roman T, et al. Among authors: hutz mh. Am J Pharmacogenomics. 2004;4(2):83-92. doi: 10.2165/00129785-200404020-00003. Am J Pharmacogenomics. 2004. PMID: 15059031 Review.

3

A promoter polymorphism (-839 C > T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children.

Genro JP, Zeni C, Polanczyk GV, Roman T, Rohde LA, Hutz MH. Genro JP, et al. Among authors: hutz mh. Am J Med Genet B Neuropsychiatr Genet. 2007 Mar 5;144B(2):215-9. doi: 10.1002/ajmg.b.30428. Am J Med Genet B Neuropsychiatr Genet. 2007. PMID: 17044101

4

No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit/hyperactivity disorder.

Zeni CP, Guimarães AP, Polanczyk GV, Genro JP, Roman T, Hutz MH, Rohde LA. Zeni CP, et al. Among authors: hutz mh. Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):391-4. doi: 10.1002/ajmg.b.30474. Am J Med Genet B Neuropsychiatr Genet. 2007. PMID: 17171656 Clinical Trial.

5

Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.

Polanczyk G, Zeni C, Genro JP, Guimarães AP, Roman T, Hutz MH, Rohde LA. Polanczyk G, et al. Among authors: hutz mh. Arch Gen Psychiatry. 2007 Feb;64(2):218-24. doi: 10.1001/archpsyc.64.2.218. Arch Gen Psychiatry. 2007. PMID: 17283289 Clinical Trial.

6

A common haplotype at the dopamine transporter gene 5' region is associated with attention-deficit/hyperactivity disorder.

Genro JP, Polanczyk GV, Zeni C, Oliveira AS, Roman T, Rohde LA, Hutz MH. Genro JP, et al. Among authors: hutz mh. Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1568-75. doi: 10.1002/ajmg.b.30863. Am J Med Genet B Neuropsychiatr Genet. 2008. PMID: 18802919

7

MAOA is associated with methylphenidate improvement of oppositional symptoms in boys with attention deficit hyperactivity disorder.

Guimarães AP, Zeni C, Polanczyk G, Genro JP, Roman T, Rohde LA, Hutz MH. Guimarães AP, et al. Among authors: hutz mh. Int J Neuropsychopharmacol. 2009 Jun;12(5):709-14. doi: 10.1017/S1461145709000212. Epub 2009 Mar 24. Int J Neuropsychopharmacol. 2009. PMID: 19309535 Free article.

8

A current update on ADHD pharmacogenomics.

Kieling C, Genro JP, Hutz MH, Rohde LA. Kieling C, et al. Among authors: hutz mh. Pharmacogenomics. 2010 Mar;11(3):407-19. doi: 10.2217/pgs.10.28. Pharmacogenomics. 2010. PMID: 20235795 Review.

9

Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses.

Genro JP, Kieling C, Rohde LA, Hutz MH. Genro JP, et al. Among authors: hutz mh. Expert Rev Neurother. 2010 Apr;10(4):587-601. doi: 10.1586/ern.10.17. Expert Rev Neurother. 2010. PMID: 20367210 Review.

10

Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder.

Roman T, Szobot C, Martins S, Biederman J, Rohde LA, Hutz MH. Roman T, et al. Among authors: hutz mh. Pharmacogenetics. 2002 Aug;12(6):497-9. doi: 10.1097/00008571-200208000-00011. Pharmacogenetics. 2002. PMID: 12172219

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

269 results

Search Page